aluates Reports

$ 0.0

Automative

Global Infantile Spasms Therapeutics Market Research Report 2026

Published Date: 2026-01-21

Report Code: QYRE-Auto-31J12684

Global Infantile Spasms Therapeutics Sales Market Report 2023

BUY CHAPTERS

Global Infantile Spasms Therapeutics Market Research Report 2026

Code: QYRE-Auto-31J12684

Report

2026-01-21

Pages:103

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Mallinckrodt plc

H.Lundbeck

Insys Therapeutics

Orphelia Pharma

Valerion Therapeutics

Catalyst Pharmaceuticals

Anavex Life Sciences

Retrophin

GW Pharmaceuticals

Infantile Spasms Therapeutics Market Size

The global Infantile Spasms Therapeutics market was valued at US$ 157 million in 2025 and is anticipated to reach US$ 201 million by 2032, at a CAGR of 3.6% from 2026 to 2032.

Infantile Spasms Therapeutics Market

An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.

Global Infantile Spasms Therapeutics key players include Mallinckrodt, H. Lundbeck, etc. Global top two manufacturers hold a share over 60%.

In terms of product, Oral is the largest segment, with a share obout 55%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.

This report delivers a comprehensive overview of the global Infantile Spasms Therapeutics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Infantile Spasms Therapeutics. The Infantile Spasms Therapeutics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Infantile Spasms Therapeutics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Infantile Spasms Therapeutics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Infantile Spasms Therapeutics Market Report

Report Metric	Details
Report Name	Infantile Spasms Therapeutics Market
Accounted market size in 2025	US$ 157 million
Forecasted market size in 2032	US$ 201 million
CAGR	3.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Oral Injection
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Mallinckrodt, H. Lundbeck, Insys Therapeutics, Orphelia Pharma, Valerion Therapeutics, Catalyst Pharmaceuticals, Anavex Life Sciences, Retrophin, GW Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Infantile Spasms Therapeutics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Infantile Spasms Therapeutics Market growing?

Ans: The Infantile Spasms Therapeutics Market witnessing a CAGR of 3.6% during the forecast period 2026-2032.

What is the Infantile Spasms Therapeutics Market size in 2032?

Ans: The Infantile Spasms Therapeutics Market size in 2032 will be US$ 201 million.

What is the market share of major companies in Infantile Spasms Therapeutics Market?

Ans: Global top two manufacturers hold a share over 60%.

What is the Infantile Spasms Therapeutics Market share by type?

Ans: In terms of product, Oral is the largest segment, with a share obout 55%.

Who are the main players in the Infantile Spasms Therapeutics Market report?

Ans: The main players in the Infantile Spasms Therapeutics Market are Mallinckrodt, H. Lundbeck, Insys Therapeutics, Orphelia Pharma, Valerion Therapeutics, Catalyst Pharmaceuticals, Anavex Life Sciences, Retrophin, GW Pharmaceuticals

What are the Application segmentation covered in the Infantile Spasms Therapeutics Market report?

Ans: The Applications covered in the Infantile Spasms Therapeutics Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Infantile Spasms Therapeutics Market report?

Ans: The Types covered in the Infantile Spasms Therapeutics Market report are Oral, Injection

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Infantile Spasms Therapeutics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Oral

1.2.3 Injection

1.3 Market by Application

1.3.1 Global Infantile Spasms Therapeutics Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Infantile Spasms Therapeutics Market Perspective (2021–2032)

2.2 Global Infantile Spasms Therapeutics Growth Trends by Region

2.2.1 Global Infantile Spasms Therapeutics Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Infantile Spasms Therapeutics Historic Market Size by Region (2021–2026)

2.2.3 Infantile Spasms Therapeutics Forecasted Market Size by Region (2027–2032)

2.3 Infantile Spasms Therapeutics Market Dynamics

2.3.1 Infantile Spasms Therapeutics Industry Trends

2.3.2 Infantile Spasms Therapeutics Market Drivers

2.3.3 Infantile Spasms Therapeutics Market Challenges

2.3.4 Infantile Spasms Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Infantile Spasms Therapeutics Players by Revenue

3.1.1 Global Top Infantile Spasms Therapeutics Players by Revenue (2021–2026)

3.1.2 Global Infantile Spasms Therapeutics Revenue Market Share by Players (2021–2026)

3.2 Global Top Infantile Spasms Therapeutics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Infantile Spasms Therapeutics Revenue

3.4 Global Infantile Spasms Therapeutics Market Concentration Ratio

3.4.1 Global Infantile Spasms Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Infantile Spasms Therapeutics Revenue in 2025

3.5 Global Key Players of Infantile Spasms Therapeutics Head Offices and Areas Served

3.6 Global Key Players of Infantile Spasms Therapeutics, Products and Applications

3.7 Global Key Players of Infantile Spasms Therapeutics, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Infantile Spasms Therapeutics Breakdown Data by Type

4.1 Global Infantile Spasms Therapeutics Historic Market Size by Type (2021–2026)

4.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Type (2027–2032)

5 Infantile Spasms Therapeutics Breakdown Data by Application

5.1 Global Infantile Spasms Therapeutics Historic Market Size by Application (2021–2026)

5.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Infantile Spasms Therapeutics Market Size (2021–2032)

6.2 North America Infantile Spasms Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Infantile Spasms Therapeutics Market Size by Country (2021–2026)

6.4 North America Infantile Spasms Therapeutics Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Infantile Spasms Therapeutics Market Size (2021–2032)

7.2 Europe Infantile Spasms Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Infantile Spasms Therapeutics Market Size by Country (2021–2026)

7.4 Europe Infantile Spasms Therapeutics Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Infantile Spasms Therapeutics Market Size (2021–2032)

8.2 Asia-Pacific Infantile Spasms Therapeutics Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Infantile Spasms Therapeutics Market Size by Region (2021–2026)

8.4 Asia-Pacific Infantile Spasms Therapeutics Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Infantile Spasms Therapeutics Market Size (2021–2032)

9.2 Latin America Infantile Spasms Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Infantile Spasms Therapeutics Market Size by Country (2021–2026)

9.4 Latin America Infantile Spasms Therapeutics Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Infantile Spasms Therapeutics Market Size (2021–2032)

10.2 Middle East & Africa Infantile Spasms Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2021–2026)

10.4 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Mallinckrodt

11.1.1 Mallinckrodt Company Details

11.1.2 Mallinckrodt Business Overview

11.1.3 Mallinckrodt Infantile Spasms Therapeutics Introduction

11.1.4 Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (2021–2026)

11.1.5 Mallinckrodt Recent Development

11.2 H. Lundbeck

11.2.1 H. Lundbeck Company Details

11.2.2 H. Lundbeck Business Overview

11.2.3 H. Lundbeck Infantile Spasms Therapeutics Introduction

11.2.4 H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (2021–2026)

11.2.5 H. Lundbeck Recent Development

11.3 Insys Therapeutics

11.3.1 Insys Therapeutics Company Details

11.3.2 Insys Therapeutics Business Overview

11.3.3 Insys Therapeutics Infantile Spasms Therapeutics Introduction

11.3.4 Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (2021–2026)

11.3.5 Insys Therapeutics Recent Development

11.4 Orphelia Pharma

11.4.1 Orphelia Pharma Company Details

11.4.2 Orphelia Pharma Business Overview

11.4.3 Orphelia Pharma Infantile Spasms Therapeutics Introduction

11.4.4 Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (2021–2026)

11.4.5 Orphelia Pharma Recent Development

11.5 Valerion Therapeutics

11.5.1 Valerion Therapeutics Company Details

11.5.2 Valerion Therapeutics Business Overview

11.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Introduction

11.5.4 Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (2021–2026)

11.5.5 Valerion Therapeutics Recent Development

11.6 Catalyst Pharmaceuticals

11.6.1 Catalyst Pharmaceuticals Company Details

11.6.2 Catalyst Pharmaceuticals Business Overview

11.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Introduction

11.6.4 Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2021–2026)

11.6.5 Catalyst Pharmaceuticals Recent Development

11.7 Anavex Life Sciences

11.7.1 Anavex Life Sciences Company Details

11.7.2 Anavex Life Sciences Business Overview

11.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Introduction

11.7.4 Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (2021–2026)

11.7.5 Anavex Life Sciences Recent Development

11.8 Retrophin

11.8.1 Retrophin Company Details

11.8.2 Retrophin Business Overview

11.8.3 Retrophin Infantile Spasms Therapeutics Introduction

11.8.4 Retrophin Revenue in Infantile Spasms Therapeutics Business (2021–2026)

11.8.5 Retrophin Recent Development

11.9 GW Pharmaceuticals

11.9.1 GW Pharmaceuticals Company Details

11.9.2 GW Pharmaceuticals Business Overview

11.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Introduction

11.9.4 GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2021–2026)

11.9.5 GW Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Mallinckrodt plc

H.Lundbeck

Insys Therapeutics

Orphelia Pharma

Valerion Therapeutics

Catalyst Pharmaceuticals

Anavex Life Sciences

Retrophin

GW Pharmaceuticals

List of Tables

Table 1. Global Infantile Spasms Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Oral

Table 3. Key Players of Injection

Table 4. Global Infantile Spasms Therapeutics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Infantile Spasms Therapeutics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Infantile Spasms Therapeutics Market Size by Region (US$ Million), 2021–2026

Table 7. Global Infantile Spasms Therapeutics Market Share by Region (2021–2026)

Table 8. Global Infantile Spasms Therapeutics Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Infantile Spasms Therapeutics Market Share by Region (2027–2032)

Table 10. Infantile Spasms Therapeutics Market Trends

Table 11. Infantile Spasms Therapeutics Market Drivers

Table 12. Infantile Spasms Therapeutics Market Challenges

Table 13. Infantile Spasms Therapeutics Market Restraints

Table 14. Global Infantile Spasms Therapeutics Revenue by Players (US$ Million), 2021–2026

Table 15. Global Infantile Spasms Therapeutics Market Share by Players (2021–2026)

Table 16. Global Top Infantile Spasms Therapeutics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Infantile Spasms Therapeutics Revenue, 2025

Table 17. Ranking of Global Top Infantile Spasms Therapeutics Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Infantile Spasms Therapeutics Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Infantile Spasms Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Infantile Spasms Therapeutics, Products and Applications

Table 21. Global Key Players of Infantile Spasms Therapeutics, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Infantile Spasms Therapeutics Market Size by Type (US$ Million), 2021–2026

Table 24. Global Infantile Spasms Therapeutics Revenue Market Share by Type (2021–2026)

Table 25. Global Infantile Spasms Therapeutics Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Infantile Spasms Therapeutics Revenue Market Share by Type (2027–2032)

Table 27. Global Infantile Spasms Therapeutics Market Size by Application (US$ Million), 2021–2026

Table 28. Global Infantile Spasms Therapeutics Revenue Market Share by Application (2021–2026)

Table 29. Global Infantile Spasms Therapeutics Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Infantile Spasms Therapeutics Revenue Market Share by Application (2027–2032)

Table 31. North America Infantile Spasms Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Infantile Spasms Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 33. North America Infantile Spasms Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Infantile Spasms Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Infantile Spasms Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Infantile Spasms Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Infantile Spasms Therapeutics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Infantile Spasms Therapeutics Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Infantile Spasms Therapeutics Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Infantile Spasms Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Infantile Spasms Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Infantile Spasms Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Infantile Spasms Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 46. Mallinckrodt Company Details

Table 47. Mallinckrodt Business Overview

Table 48. Mallinckrodt Infantile Spasms Therapeutics Product

Table 49. Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (US$ Million), 2021–2026

Table 50. Mallinckrodt Recent Development

Table 51. H. Lundbeck Company Details

Table 52. H. Lundbeck Business Overview

Table 53. H. Lundbeck Infantile Spasms Therapeutics Product

Table 54. H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (US$ Million), 2021–2026

Table 55. H. Lundbeck Recent Development

Table 56. Insys Therapeutics Company Details

Table 57. Insys Therapeutics Business Overview

Table 58. Insys Therapeutics Infantile Spasms Therapeutics Product

Table 59. Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (US$ Million), 2021–2026

Table 60. Insys Therapeutics Recent Development

Table 61. Orphelia Pharma Company Details

Table 62. Orphelia Pharma Business Overview

Table 63. Orphelia Pharma Infantile Spasms Therapeutics Product

Table 64. Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (US$ Million), 2021–2026

Table 65. Orphelia Pharma Recent Development

Table 66. Valerion Therapeutics Company Details

Table 67. Valerion Therapeutics Business Overview

Table 68. Valerion Therapeutics Infantile Spasms Therapeutics Product

Table 69. Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (US$ Million), 2021–2026

Table 70. Valerion Therapeutics Recent Development

Table 71. Catalyst Pharmaceuticals Company Details

Table 72. Catalyst Pharmaceuticals Business Overview

Table 73. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product

Table 74. Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (US$ Million), 2021–2026

Table 75. Catalyst Pharmaceuticals Recent Development

Table 76. Anavex Life Sciences Company Details

Table 77. Anavex Life Sciences Business Overview

Table 78. Anavex Life Sciences Infantile Spasms Therapeutics Product

Table 79. Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (US$ Million), 2021–2026

Table 80. Anavex Life Sciences Recent Development

Table 81. Retrophin Company Details

Table 82. Retrophin Business Overview

Table 83. Retrophin Infantile Spasms Therapeutics Product

Table 84. Retrophin Revenue in Infantile Spasms Therapeutics Business (US$ Million), 2021–2026

Table 85. Retrophin Recent Development

Table 86. GW Pharmaceuticals Company Details

Table 87. GW Pharmaceuticals Business Overview

Table 88. GW Pharmaceuticals Infantile Spasms Therapeutics Product

Table 89. GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (US$ Million), 2021–2026

Table 90. GW Pharmaceuticals Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

Table 94. Authors List of This Report

List of Figures

Figure 1. Infantile Spasms Therapeutics Picture

Figure 2. Global Infantile Spasms Therapeutics Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Infantile Spasms Therapeutics Market Share by Type: 2025 vs 2032

Figure 4. Oral Features

Figure 5. Injection Features

Figure 6. Global Infantile Spasms Therapeutics Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Infantile Spasms Therapeutics Market Share by Application: 2025 vs 2032

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Other Case Studies

Figure 11. Infantile Spasms Therapeutics Report Years Considered

Figure 12. Global Infantile Spasms Therapeutics Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Infantile Spasms Therapeutics Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Infantile Spasms Therapeutics Market Share by Region: 2025 vs 2032

Figure 15. Global Infantile Spasms Therapeutics Market Share by Players in 2025

Figure 16. Global Infantile Spasms Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Infantile Spasms Therapeutics Revenue in 2025

Figure 18. North America Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Infantile Spasms Therapeutics Market Share by Country (2021–2032)

Figure 20. United States Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Infantile Spasms Therapeutics Market Share by Country (2021–2032)

Figure 24. Germany Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Infantile Spasms Therapeutics Market Share by Region (2021–2032)

Figure 32. China Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Infantile Spasms Therapeutics Market Share by Country (2021–2032)

Figure 40. Mexico Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Infantile Spasms Therapeutics Market Share by Country (2021–2032)

Figure 44. Israel Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Infantile Spasms Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Mallinckrodt Revenue Growth Rate in Infantile Spasms Therapeutics Business (2021–2026)

Figure 48. H. Lundbeck Revenue Growth Rate in Infantile Spasms Therapeutics Business (2021–2026)

Figure 49. Insys Therapeutics Revenue Growth Rate in Infantile Spasms Therapeutics Business (2021–2026)

Figure 50. Orphelia Pharma Revenue Growth Rate in Infantile Spasms Therapeutics Business (2021–2026)

Figure 51. Valerion Therapeutics Revenue Growth Rate in Infantile Spasms Therapeutics Business (2021–2026)

Figure 52. Catalyst Pharmaceuticals Revenue Growth Rate in Infantile Spasms Therapeutics Business (2021–2026)

Figure 53. Anavex Life Sciences Revenue Growth Rate in Infantile Spasms Therapeutics Business (2021–2026)

Figure 54. Retrophin Revenue Growth Rate in Infantile Spasms Therapeutics Business (2021–2026)

Figure 55. GW Pharmaceuticals Revenue Growth Rate in Infantile Spasms Therapeutics Business (2021–2026)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Epilepsy Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Epileptic Seizures Treatment Market Research Report 2024

Global Epilepsy in Children Market Research Report 2024

Global Infantile Spasm Treatment Market Research Report 2024

Global West Syndrome Market Research Report 2024

Global Developmental and Epileptic Encephalopathies DEE Market Research Report 2024

Anti epileptic Drugs for Pediatrics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Asperger Syndrome Treatment Market Research Report 2024

Global Childhood Absence Epilepsy Treatment Market Research Report 2024

Epilepsy Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Epilepsy Therapeutic Market Research Report 2024

Global Cerebral Palsy Treatment Market Insights Forecast to 2030

Global Rett Syndrome Market Insights Forecast to 2030

Paediatric Spasticity Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sturge Weber Syndrome SWS Treatment Market Research Report 2024

Global Phelan McDermid Syndrome PMS Market Research Report 2024

Global Smith Lemli Opitz Syndrome Market Insights Forecast to 2030

Aicardi Syndrome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Petit Mal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions